Innovating Works

GLPG

Desconocido
HIT-CF: Personalised Treatment For Cystic Fibrosis Patients With Ultra rare CFTR Mutations and beyond GALAPAGOS participó en un H2020: H2020-SC1-2016-2017 In our HIT-CF project, we aim to bring personalised disease modifying therapies to cystic fibrosis (CF) patients with ultra-rare CFTR mutati...
2017-11-28 - 2025-06-30 | Financiado
ND4ID: New Diagnostics for Infectious Diseases ND4ID Infectious diseases are a major burden to public health and the global economy, not in the least due to antimicrobial resistance. Rapid poin...
2015-07-31 - 2020-02-29 | Financiado
ZF-CANCER: Developing high thoughput bioassays for human cancers in zebrafish GALAPAGOS participó en un FP7: Recently the zebrafish has emerged as a new important system for cancer research because the zebrafish genome contains all orthologs of huma...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.